| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 150, 563-578, Copyright © 1997 by American Society for Investigative Pathology
REGULAR ARTICLES |
AJ Demetris, N Murase, Q Ye, FH Galvao, C Richert, R Saad, S Pham, RJ Duquesnoy, A Zeevi, JJ Fung and TE Starzl
Department of Pathology, University of Pittsburgh Medical Center, Pennsylvania, USA.
Sequential analysis of changes that lead to chronic rejection was undertaken in an animal model of chronic rejection and obliterative arteriopathy. Brown Norway rats are pretreated with a Lewis bone marrow infusion or a Lewis orthotopic liver allograft and a short course of immunosuppression. They are challenged 100 days later with a Lewis heterotopic heart graft without immunosuppression. The heart grafts in both groups undergo a transient acute rejection, but all rats are operationally tolerant; the heart grafts are accepted and remain beating for more than 100 days. Early arterial remodeling, marked by arterial bromodeoxyuridine incorporation, occurred in both groups between 5 and 30 days during the transient acute rejection. It coincided with the presence of interstitial (but not arterial intimal) inflammation and lymphatic disruption and resulted in mild intimal thickening. Significant arterial narrowing occurred only in the bone- marrow-pretreated rats between 60 and 100 days. It was associated with T lymphocyte and macrophage inflammation of the heart graft that accumulated in the endocardium and arterial intima and adventitia near draining lymphatics. There also was loss of passenger leukocytes from the heart graft, up-regulation of cytokine mRNA and major histocompatibility class II on the endothelium, and focal disruption of lymphatics. In contrast, long-surviving heart grafts from the Lewis orthotopic liver allograft pretreated group are near normal and freedom from chronic rejection in this group was associated with persistence of donor major histocompatibility class-II-positive hematolymphoid cells, including OX62+ donor dendritic cells. This study offers insights into two different aspects of chronic rejection: 1) possible mechanisms underlying the persistent immunological injury and 2) the association between immunological injury and the development of obliterative arteriopathy. Based on the findings, it is not unreasonable to raise the testable hypothesis that direct presentation of alloantigen by donor antigen-presenting cells is required for long-term, chronic- rejection-free allograft acceptance. In addition, chronic intermittent lymphatic disruption is implicated as a possible mechanism for the association between chronic interstitial allograft inflammation and the development of obliterative arteriopathy.
This article has been cited by other articles:
 |
|
 |
|
  Q. Ye, Y. L. Wu, L. M. Foley, T. K. Hitchens, D. F. Eytan, H. Shirwan, and C. Ho Longitudinal Tracking of Recipient Macrophages in a Rat Chronic Cardiac Allograft Rejection Model With Noninvasive Magnetic Resonance Imaging Using Micrometer-Sized Paramagnetic Iron Oxide Particles Circulation, July 8, 2008; 118(2): 149 - 156. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M Blois, U. Kammerer, C. A. Soto, M. C Tometten, V. Shaikly, G. Barrientos, R. Jurd, D. Rukavina, A. W Thomson, B. F Klapp, et al. Dendritic Cells: Key to Fetal Tolerance? Biol Reprod, October 1, 2007; 77(4): 590 - 598. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. C. Tung, G. Cui, K. Oshima, H. Laks, and L. Sen Balanced expression of mitochondrial apoptosis regulatory proteins correlates with long-term survival of cardiac allografts Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2832 - H2841. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Andrassy, S. Kusaka, E. Jankowska-Gan, J. R. Torrealba, L. D. Haynes, B. R. Marthaler, R. C. Tam, B. M.-W. Illigens, N. Anosova, G. Benichou, et al. Tolerance to Noninherited Maternal MHC Antigens in Mice J. Immunol., November 15, 2003; 171(10): 5554 - 5561. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-Y. Tsui, X. Wu, C.-K. Lau, D. W.Y. Ho, T. Xu, Y.-T. Siu, and S.-T. Fan Prevention of Chronic Deterioration of Heart Allograft by Recombinant Adeno-Associated Virus-Mediated Heme Oxygenase-1 Gene Transfer Circulation, May 27, 2003; 107(20): 2623 - 2629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. W. Miller, E. Dai, P. Nash, L. Liu, C. Icton, D. Klironomos, L. Fan, P. N. Nation, R. Zhong, G. McFadden, et al. Inhibition of Transplant Vasculopathy in a Rat Aortic Allograft Model After Infusion of Anti-Inflammatory Viral Serpin Circulation, April 4, 2000; 101(13): 1598 - 1605. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. REMUZZI, C. ZOJA, E. GAGLIARDINI, D. CORNA, M. ABBATE, and A. BENIGNI Combining an Antiproteinuric Approach with Mycophenolate Mofetil Fully Suppresses Progressive Nephropathy of Experimental Animals J. Am. Soc. Nephrol., July 1, 1999; 10(7): 1542 - 1549. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. A. ROSSINI, D. L. GREINER, and J. P. MORDES Induction of Immunologic Tolerance for Transplantation Physiol Rev, January 1, 1999; 79(1): 99 - 141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. E. Starzl and R. M. Zinkernagel Antigen Localization and Migration in Immunity and Tolerance N. Engl. J. Med., December 24, 1998; 339(26): 1905 - 1913. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Hasegawa, G. Becker, H. Nagano, P. Libby, and R. N. Mitchell Pattern of Graft- and Host-Specific MHC Class II Expression in Long-Term Murine Cardiac Allografts : Origin of Inflammatory and Vascular Wall Cells Am. J. Pathol., July 1, 1998; 153(1): 69 - 79. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
